Huntington’s Chorea - Causes, Treatment & When to See a Doctor

```html

What is Huntington’s Chorea?

Huntington’s chorea, more commonly called Huntington disease (HD), is a progressive, neuro‑degenerative disorder characterized by involuntary, jerky movements (chorea), cognitive decline, and psychiatric changes. The disease is caused by a mutation in the HTT gene on chromosome 4, leading to an abnormal expansion of CAG repeats. The mutant huntingtin protein gradually damages neurons, especially in the basal ganglia, which controls movement, mood, and thought processes. Symptoms typically appear between the ages of 30 and 50, but juvenile and late‑onset forms exist.

Common Causes

Huntington’s chorea itself is a single genetic disease, but the choreiform movements seen in HD can also arise from other conditions. Understanding the differential diagnoses helps clinicians avoid mis‑diagnosis and guides appropriate testing.

• Genetic: Huntington disease (CAG repeat expansion in the HTT gene).
• Other trinucleotide repeat disorders:
  • Spinocerebellar ataxias (e.g., SCA1, SCA3)
  • Dentatorubral‑pallidoluysian atrophy (DRPLA)
• Autoimmune:
  • Sydenham’s chorea (post‑streptococcal rheumatic fever)
  • Lupus‑associated chorea
• Metabolic/toxic:
  • Wilson disease (copper overload)
  • Hyperthyroidism
  • Medication‑induced (e.g., levodopa, antipsychotics, anti‑epileptics)
• Neurodegenerative:
  • Parkinson’s disease with dyskinesia
  • Progressive supranuclear palsy
• Structural brain lesions:
  • Stroke affecting the basal ganglia
  • Brain tumor or cyst

Associated Symptoms

In Huntington disease, chorea rarely occurs in isolation. The classic triad includes:

• Motor disturbances – involuntary jerking, dystonia, bradykinesia, balance problems, and difficulty with fine motor tasks.
• Cognitive decline – impaired planning, attention, memory loss, slowed processing, and eventually dementia.
• Psychiatric changes – depression, anxiety, irritability, obsessive‑compulsive behaviors, and sometimes psychosis.

Additional features that frequently accompany HD are:

• Weight loss despite normal intake (due to increased energy expenditure and swallowing difficulties).
• Sleep disturbances (insomnia or fragmented sleep).
• Speech problems (dysarthria) and difficulty swallowing (dysphagia).
• Impaired gait and frequent falls.
• Urinary urgency or incontinence.

When to See a Doctor

Because HD is progressive and currently incurable, early medical attention can improve quality of life and allow for genetic counseling.

• New onset of unpredictable, dance‑like movements that worsen with stress.
• Family history of Huntington disease or unexplained early‑onset dementia.
• Sudden or progressive changes in mood, behavior, or cognition without obvious cause.
• Difficulty with coordination, speech, or swallowing that interferes with daily activities.
• Any unexplained weight loss or sleep disruption accompanied by motor changes.

If you or a loved one exhibit these signs, schedule an appointment with a neurologist or a genetic counselor promptly.

Diagnosis

Diagnosing Huntington’s chorea involves a combination of clinical evaluation, family history, and definitive genetic testing.

1. Clinical Examination

• Neurological exam to assess chorea, rigidity, reflexes, gait, and speech.
• Mental‑status testing for memory, executive function, and mood.

2. Genetic Testing

The gold‑standard test detects the number of CAG repeats in the HTT gene. A repeat length ≥36 is pathogenic; 27–35 is considered an intermediate allele with reduced penetrance.

Testing is usually performed on a blood sample. Pre‑ and post‑test genetic counseling is strongly recommended because results have implications for the individual and family members.

3. Imaging (Supportive)

• MRI or CT scan: May show caudate nucleus atrophy and enlarged ventricles, supporting the diagnosis and excluding other causes.
• Functional imaging (PET or SPECT): Can demonstrate reduced glucose metabolism in the basal ganglia.

4. Laboratory Work‑up (to rule out mimics)

• Serum copper, ceruloplasmin (Wilson disease).
• Thyroid function tests.
• Autoimmune panel (ANA, anti‑dsDNA) if lupus is suspected.

Treatment Options

There is no cure for Huntington disease, but a multidisciplinary approach can slow symptom progression, manage complications, and improve quality of life.

Pharmacologic Therapy

• Tetrabenazine (or deutetrabenazine): First‑line for chorea; works by depleting dopamine.
• Antipsychotics (e.g., risperidone, olanzapine): Helpful for severe chorea and psychosis.
• Antidepressants (SSRIs, SNRIs): Treat depression and anxiety.
• Mood stabilizers (valproic acid, carbamazepine): May reduce irritability and impulsivity.
• Modafinil or methylphenidate: Can improve daytime alertness and executive function.

Non‑Pharmacologic Interventions

• Physical therapy: Stretching, balance training, and gait re‑education to reduce fall risk.
• Occupational therapy: Adaptive equipment for dressing, eating, and writing.
• Speech‑language therapy: Exercises to maintain articulation and safe swallowing techniques.
• Psychological support: Cognitive‑behavioral therapy, support groups, and counseling for patients and caregivers.
• Nutrition counseling: High‑calorie, high‑protein diets; supplementation if dysphagia limits intake.
• Social services: Planning for long‑term care, legal guardianship, and advance directives.

Clinical Trials & Emerging Therapies

Researchers are exploring gene‑silencing techniques (antisense oligonucleotides, RNA interference), CRISPR‑based editing, and neuroprotective agents. Patients interested in experimental treatments should discuss enrollment with a specialist center or review ongoing trials on ClinicalTrials.gov.

Prevention Tips

Because HD is an inherited autosomal‑dominant disorder, primary prevention of the disease itself is not possible. However, the following steps can reduce the impact on individuals and families:

• Genetic counseling: Couples with a known family history should meet a certified counselor before having children.
• Pre‑implantation genetic diagnosis (PGD): Allows selection of embryos without the pathogenic CAG expansion during in‑vitro fertilization.
• Prenatal testing: Chorionic villus sampling or amniocentesis can determine fetal status when the mutation is known.
• Lifestyle measures for symptomatic individuals:
  • Regular aerobic exercise (e.g., walking, swimming) to preserve motor function.
  • Balanced diet rich in antioxidants and omega‑3 fatty acids.
  • Avoidance of alcohol and illicit drugs, which can exacerbate neurodegeneration.
• Vaccination: Keep up‑to‑date with flu and pneumonia vaccines to prevent infections that could worsen respiratory function.

Emergency Warning Signs

Key Take‑aways

Huntington’s chorea is a hereditary neurodegenerative condition marked by involuntary movements, cognitive decline, and psychiatric disturbances. Early recognition, genetic testing, and a coordinated care team can slow progression, manage symptoms, and support patients and families through the challenges of this lifelong disease. Always seek professional medical advice if new symptoms appear or existing problems worsen.

References:

• Mayo Clinic. “Huntington disease.” https://www.mayoclinic.org
• National Institute of Neurological Disorders and Stroke (NINDS). “Huntington Disease Information Page.” https://www.ninds.nih.gov
• Cleveland Clinic. “Huntington’s Disease.” https://my.clevelandclinic.org
• World Health Organization. “Genetic Counseling.” https://www.who.int
• GeneReviews. “Huntington Disease.” https://www.ncbi.nlm.nih.gov

```